Pfizer Clarifies M&A Philosophy
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer's acquisition of Idun should not be viewed as a "departure" from the company's historical approach to mergers and acquisitions, Pfizer Senior VP-Science & Technology Peter Corr said in a letter to "The Pink Sheet" DAILY